Brevan Howard Capital Management LP Has $2.08 Million Stake in Teladoc Health, Inc. (NYSE:TDOC)

Brevan Howard Capital Management LP lifted its position in shares of Teladoc Health, Inc. (NYSE:TDOC - Free Report) by 49.8% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 228,351 shares of the health services provider's stock after buying an additional 75,961 shares during the period. Brevan Howard Capital Management LP owned about 0.13% of Teladoc Health worth $2,076,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also bought and sold shares of TDOC. Maple Rock Capital Partners Inc. boosted its holdings in shares of Teladoc Health by 189.5% during the 4th quarter. Maple Rock Capital Partners Inc. now owns 3,561,000 shares of the health services provider's stock worth $32,369,000 after buying an additional 2,331,000 shares during the period. Vanguard Group Inc. boosted its position in shares of Teladoc Health by 5.9% in the fourth quarter. Vanguard Group Inc. now owns 18,463,155 shares of the health services provider's stock valued at $167,830,000 after acquiring an additional 1,029,829 shares during the period. Renaissance Technologies LLC increased its position in Teladoc Health by 15.5% during the fourth quarter. Renaissance Technologies LLC now owns 5,674,542 shares of the health services provider's stock worth $51,582,000 after acquiring an additional 763,265 shares during the period. Nisa Investment Advisors LLC grew its position in shares of Teladoc Health by 20,936.8% during the 4th quarter. Nisa Investment Advisors LLC now owns 426,206 shares of the health services provider's stock worth $3,874,000 after purchasing an additional 424,180 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. increased its holdings in shares of Teladoc Health by 18.7% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 2,443,713 shares of the health services provider's stock worth $22,213,000 after purchasing an additional 384,528 shares during the period. Institutional investors and hedge funds own 76.82% of the company's stock.

Teladoc Health Trading Up 0.6 %

Shares of TDOC stock traded up $0.04 during trading hours on Friday, hitting $7.12. 3,480,433 shares of the company's stock traded hands, compared to its average volume of 6,252,131. The stock has a market cap of $1.25 billion, a PE ratio of -1.23 and a beta of 1.82. The stock's 50 day simple moving average is $7.75 and its 200 day simple moving average is $9.41. The company has a quick ratio of 1.69, a current ratio of 1.73 and a debt-to-equity ratio of 0.66. Teladoc Health, Inc. has a 12 month low of $6.35 and a 12 month high of $15.21.

Teladoc Health (NYSE:TDOC - Get Free Report) last announced its earnings results on Wednesday, February 26th. The health services provider reported ($0.28) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.21) by ($0.07). Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%. The company had revenue of $640.49 million for the quarter, compared to the consensus estimate of $639.44 million. On average, sell-side analysts anticipate that Teladoc Health, Inc. will post -1.16 EPS for the current year.

Insider Transactions at Teladoc Health

In other Teladoc Health news, insider Adam C. Vandervoort sold 11,011 shares of Teladoc Health stock in a transaction that occurred on Thursday, March 20th. The stock was sold at an average price of $8.42, for a total value of $92,712.62. Following the completion of the sale, the insider now directly owns 64,308 shares in the company, valued at approximately $541,473.36. The trade was a 14.62 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Corporate insiders own 0.58% of the company's stock.

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on TDOC. Evercore ISI reduced their price target on Teladoc Health from $8.00 to $7.00 and set an "in-line" rating on the stock in a research report on Thursday, May 1st. The Goldman Sachs Group dropped their price target on Teladoc Health from $13.00 to $10.00 and set a "buy" rating for the company in a research note on Thursday, May 1st. Needham & Company LLC reissued a "hold" rating on shares of Teladoc Health in a report on Thursday, May 1st. Royal Bank of Canada increased their price target on shares of Teladoc Health from $11.00 to $12.00 and gave the stock an "outperform" rating in a research report on Friday, January 24th. Finally, Citigroup decreased their price objective on shares of Teladoc Health from $11.00 to $8.75 and set a "neutral" rating on the stock in a research note on Friday, April 25th. Twelve research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of "Hold" and a consensus price target of $9.71.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.